A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Acne Vulgaris
Interventions
DRUG

Olumacostat Glasaretil

OTHER

Vehicle

Trial Locations (34)

14623

Skin Search of Rochester, Inc., Rochester

20850

Lawrence J. Green, MD, LLC, Rockville

24501

The Education & Research Foundation, Inc., Lynchburg

27262

Dermatology Consulting Services, High Point

32771

International Clinical Research - US, LLC, Sanford

33162

Tory Sullivan MD PA, North Miami Beach

33414

Visions Clinical Research, Wellington

33609

MOORE Clinical Research, Inc., Tampa

36608

Coastal Clinical Research, Inc., Mobile

37130

International Clinical Research - Tennessee LLC, Murfreesboro

37922

The Skin Wellness Center, Knoxville

40217

DermResearch, PLLC, Louisville

48038

Michigan Center for Skin Care Research, Clinton Township

48202

Henry Ford Health System, Detroit

55432

Minnesota Clinical Study Center, Fridley

77004

Center for Clinical Studies, LTD. LLP, Houston

77056

Suzanne Bruce & Associates, PA. The Center for Skin Research, Houston

77494

Suzanne Bruce & Associates, PA. The Center for Skin Research, Katy

77845

J&S Studies, Inc., College Station

78229

Progressive Clinical Research, PA, San Antonio

78660

Austin Institute for Clinical Research, Pflugerville

78759

DermResearch, Inc, Austin

84117

Dermatology Research Center, Inc., Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

89144

Las Vegas Dermatology, Las Vegas

92123

University Clinical Trials, Inc., San Diego

94136

T. Joseph Raoof, MD, Inc., Encino

99202

Premier Clinical Research, Spokane

T2G1B1

Kirk Barber Research, Calgary

V3V0C6

Enverus Medical Research, Surrey

L3P1X2

Lynderm Research, Markham

N8W 5L7

Windsor Clinical Research, Inc., Windsor

H2K 4L5

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermetologique du Quebec Metropolitain (CRDQ), Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dermira, Inc.

INDUSTRY

NCT02431052 - A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris | Biotech Hunter | Biotech Hunter